Evidence map›Paper›PMID 42297736›Full record

ArticleDiabetes, obesity & metabolism2026

T2D Management Among a Community Clinic Patient Sample After California's May 2022 Medicaid Expansion.

Annie E Ro, Jung Min Choi, Celina Morales, Nicole Tavares Kuhn, Cecilia Wu, Luohua Jiang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Annie E RoDepartment of Health, Society, & Behavior, Wen School of Population and Public Health, 856 Health Sciences Quad, Suite 3600 University of California, Irvine, Irvine, California, USA.ORCID 0000-0001-9684-5566
Jung Min ChoiDepartment of Health, Society, & Behavior, Wen School of Population and Public Health, 856 Health Sciences Quad, Suite 3600 University of California, Irvine, Irvine, California, USA.
Celina MoralesDepartment of Health, Society, & Behavior, Wen School of Population and Public Health, 856 Health Sciences Quad, Suite 3600 University of California, Irvine, Irvine, California, USA.
Nicole Tavares KuhnEisner Health, Los Angeles, California, USA.
Cecilia WuGracelight Community Health, Los Angeles, California, USA.
Luohua JiangDepartment of Epidemiology and Biostatistics, Wen School of Population and Public Health University of California, Irvine, California, USA.

Funding

UCLA-UCI Center for Eliminating Cardio-Metabolic Disparities in Multi-Ethnic Populations (UC END-DISPARITIES)P50MD017366 · NIMHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BODEN-ALBALA, BERNADETTE MARIE, BROWN, ARLEEN F. · 2021 to 2025
$17.3M
Google Health Equity AwardNIMHD NIH HHS P50 MD017366UCLA-UCI Center for Advancing Solutions to Cardiometabolic Health (CASCADE) NIH/NIMHD P50-MD017366
6 · The paper itself

Abstract

aimsIn May 2022, California expanded its Medicaid program ('Medi-Cal') to all low-income adults over 50 years, regardless of immigration status. We compare haemoglobin A1c (HbA1c) and body mass index (BMI) among undocumented patients with Type 2 diabetes mellitus (T2D) in a primary care setting before and after the expansion. MATERIALS AND

methodsThe study focused on encounters from undocumented and documented patients from two community clinics in Los Angeles County between May 1, 2021 to June 29, 2023 (n = 14 028). The primary outcomes were HbA1c and BMI. We included documented patients to compare to secular T2D trends. We used generalized linear mixed models to estimate the changes in HbA1c and BMI pre/post May 2022 and whether there were differential changes by immigration status. We also stratified by treatment status, as Medi-Cal offered undocumented patients access to newer classes of T2D therapeutics.

resultsPatients' mean age was 61.1 years, 65.1% were female and 80.9% were Latino. Both undocumented and documented patients saw significant declines after the policy. HbA1c declined across all encounters by 0.22 points (95% CI = -0.27, -0.18) and BMI declined by 0.15 points (95% CI = -0.21, -0.10); there were no significant differences by immigration status. Patients on the new medications experienced bigger drops in HbA1c and BMI compared to those who were not on the new medications after the policy was enacted. Again, this did not vary by immigration status.

conclusionsT2D management improved among both undocumented and documented patients after Medi-Cal expansion. These improvements may reflect access to new classes of T2D medication for all patients.

Indexed as

Diabetes Mellitus, Type 2MedicaidUndocumented ImmigrantsAgedBody Mass IndexCaliforniaFemaleGlycated HemoglobinHealth Services AccessibilityHumansMaleMiddle AgedPovertyPrimary Health CareUnited StatesGlycated Hemoglobinhemoglobin A1c protein, humanaccess to careMedicaidprimary careT2D

Identifiers

PMID42297736
PMCPMC13448954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.